Stock Scorecard
Stock Summary for AVITA Medical Inc (RCEL) - $14.58 as of 9/28/2023 8:11:50 PM EST
Total Score
8 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for RCEL
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for RCEL
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for RCEL
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for RCEL
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for RCEL
Financial Details for RCEL
Company Overview |
|
|---|---|
| Ticker | RCEL |
| Company Name | AVITA Medical Inc |
| Country | USA |
| Description | AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 6/30/2023 |
| Next Earnings Date | 11/8/2023 |
Stock Price History |
|
| Last Day Price | 14.58 |
| Last Day Price Updated | 9/28/2023 8:11:50 PM EST |
| Last Day Volume | 66,447 |
| Average Daily Volume | 97,015 |
| 52-Week High | 21.70 |
| 52-Week Low | 4.41 |
| Last Price to 52 Week Low | 230.61 % |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 82.78 |
| Sector PE | 47.89 |
| 5-Year Average PE | -14.40 |
| Free Cash Flow Ratio | 3.93 |
| Industry Free Cash Flow Ratio | 69.10 |
| Sector Free Cash Flow Ratio | 31.90 |
| Current Ratio Most Recent Quarter | 5.61 |
| Total Cash Per Share | 3.71 |
| Book Value Per Share Most Recent Quarter | 0.54 |
| Price to Book Ratio | 2.10 |
| Industry Price to Book Ratio | 6.78 |
| Sector Price to Book Ratio | 21.80 |
| Price to Sales Ratio Twelve Trailing Months | 6.63 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.43 |
| Sector Price to Sales Ratio Twelve Trailing Months | 3.72 |
Share Statistics |
|
| Total Shares Outstanding | 25,478,300 |
| Market Capitalization | 371,473,614 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00 % |
| 5-Year Dividend Payments Count | 0 |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00 % |
| Annual Earnings Growth | -0.31 % |
| Reported EPS 12 Trailing Months | -1.22 |
| Reported EPS Past Year | -1.22 |
| Reported EPS Prior Year | -1.21 |
| Net Income Twelve Trailing Months | -30,545,000 |
| Net Income Past Year | -26,665,000 |
| Net Income Prior Year | -26,583,000 |
| Quarterly Revenue Growth YOY | 41.00 % |
| 5-Year Revenue Growth | 84.58 % |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 94,609,000 |
| Total Cash Past Year | 94,609,000 |
| Total Cash Prior Year | 140,520,000 |
| Net Cash Position Most Recent Quarter | 94,609,000 |
| Net Cash Position Past Year | 94,609,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 68,647,000 |
| Total Stockholder Equity Prior Year | 84,740,000 |
| Total Stockholder Equity Most Recent Quarter | 68,647,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.61 |
| MACD Signal | -0.51 |
| 20-Day Bollinger Lower Band | 10.78 |
| 20-Day Bollinger Middle Band | 16.10 |
| 20-Day Bollinger Upper Band | 21.41 |
| Beta | 1.18 |
| RSI | 29.86 |
| 50-Day SMA | 12.10 |
| 200-Day SMA | 18.49 |
System |
|
| Modified | 9/28/2023 9:58:28 AM EST |